Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial of fissurectomy and botulinum toxin injection versus island flap in the management of chronic anal fissure
ISRCTN ISRCTN55110272
ClinicalTrials.gov identifier
Public title Randomised controlled trial of fissurectomy and botulinum toxin injection versus island flap in the management of chronic anal fissure
Scientific title
Acronym N/A
Serial number at source N0213168035
Study hypothesis To determine whether fissurectomy and botox injection or island advancement flap is superior in the surgical management of chronic anal fissure.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Fissurectomy
Participants - inclusion criteria 1. Chronic anal fissure resistant to 6 weeks GTN therapy
2. Features of fissure chronicity (skin tag, induration)
3. Suitable for day case surgery
Participants - exclusion criteria 1. Concurrent peri-anal disease
2. Previous fissure surgery
Anticipated start date 01/08/2005
Anticipated end date 06/04/2007
Status of trial Stopped
Patient information material
Target number of participants 35 patients in each arm.
Interventions Anal fissure is a painful type of ulcer around the anal canal. It often does not respond to topical therapy and surgery has to be considered. Current treatment has a risk of incontinence after surgery. We wish to look at two different kinds of surgery which do not have any risk of disturbing continence, and decide which is superior in managing anal fissure. The first is surgical removal of the fissure together with an injection of botox. The second is surgical removal of the fissure with a flap of skin to cover the wound. Both techniques avoid cutting of the 'sphincter' and so do not disturb continence.

Added 28 August 2008: trial stopped due to poor recruitment.
Primary outcome measure(s) Healing rates of anal fissure at 4, 12 and 24 weeks post surgery.
Secondary outcome measure(s) 1. Pain on defecation as assessed by Visual analogue score for 10 days post surgery
2. Patient's general health as assessed by SF-12 questionnaire at 24 weeks
3. Continence at 4, 12 and 24 weeks post surgery as assessed by the Cleveland incontinence score
Sources of funding Royal West Sussex NHS Trust (UK), NHS R&D Support Funding
Trial website
Publications
Contact name Mr  NPJ  Cripps
  Address Royal West Sussex NHS Trust
St Richard's Hospital
Spitalfield Lane
  City/town Chichester
  Zip/Postcode PO19 6SE
  Country United Kingdom
  Tel +44 01243 831593
  Fax +44
  Email neil.cripps@rws-tr.nhs.uk
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 06/10/2011
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central